M2M with Ravi Ananthanarayanan

Mint 2018-02-16

Views 17

Ranbaxy Laboratories should have seen its shares soar with its launch of a generic version of the drug Lipitor in the US. So why are investors not enthused?
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
M2M with Mobis Philipose
play
01:38

M2M with Mobis Philipose
M2M on IT Services Sector
play
01:24

M2M on IT Services Sector
M2M on State Electricity Boards
play
01:09

M2M on State Electricity Boards
Artists At Work | Ravi Subramanian
play
02:35

Artists At Work | Ravi Subramanian
India is rising in the field of digital economy: Ravi Shankar Prasad
play
02:02

India is rising in the field of digital economy: Ravi Shankar Prasad
NGT clears deck for Sri Sri Ravi Shankar’s Art of Living event, slaps Rs5 Crore fine
play
03:07

NGT clears deck for Sri Sri Ravi Shankar’s Art of Living event, slaps Rs5 Crore fine
Interview: Ravi Venkatesh, Director, Infosys
play
02:08

Interview: Ravi Venkatesh, Director, Infosys
Ravi Shastri is the new team India coach
play
03:01

Ravi Shastri is the new team India coach
Khaitan & Co Partner Ravi Kulkarni | Women on Board
play
01:41

Khaitan & Co Partner Ravi Kulkarni | Women on Board
Remembering Pandit Ravi Shankar on his 96th birthday
play
00:39

Remembering Pandit Ravi Shankar on his 96th birthday
BJP's Ravi Shankar Prasad on forming a stable government
play
00:35

BJP's Ravi Shankar Prasad on forming a stable government
Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
play
00:00

Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives